Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder.

Androgen deprivation therapy (ADT) results in testosterone suppression, a hypothesized mechanism linking ADT to depressive symptoms. This study investigated the relationship between ADT and the risk of subsequently being diagnosed with depressive disorder (DD) during a 3-year follow-up period. The p...

Descripción completa

Detalles Bibliográficos

Autores principales:	Shiu-Dong Chung, Li-Ting Kao, Herng-Ching Lin, Sudha Xirasagar, Chung-Chien Huang, Hsin-Chien Lee
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Public Library of Science (PLoS) 2017-01-01
Colección:	PLoS ONE
Acceso en línea:	https://doi.org/10.1371/journal.pone.0173266
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!